{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:25:00Z","timestamp":1787005500648,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1067\/mhj.2001.115439","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T18:14:26Z","timestamp":1030212866000},"page":"93-98","source":"Crossref","is-referenced-by-count":36,"title":["Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: A 6-month double-blind comparison with propafenone and placebo"],"prefix":"10.1067","volume":"142","author":[{"given":"Michal","family":"Tendera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Wnuk-Wojnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Kulakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3zef","family":"Malolepszy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.","family":"Kozlowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Krzeminska-Pakula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Szechinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waclaw","family":"Droszcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalina","family":"Kawecka-Jaszcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazyna","family":"Swiatecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Witold","family":"Ruzyllo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Graff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mhj.2001.115439_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0002-9149(97)89120-5","article-title":"Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation\/flutter","volume":"77","author":"Aliot","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2001.115439_bib2","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1001\/archinte.1986.00360230139020","article-title":"Incidence of symptomatic tachycardia in untreated patients with paroxysmal supraventricular tachycardia","volume":"146","author":"Sintetos","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.1067\/mhj.2001.115439_bib3","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-9149(97)00025-8","article-title":"Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation","volume":"79","author":"Lee","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2001.115439_bib4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.7326\/0003-4819-114-7-539","article-title":"Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias: a randomized, placebo-controlled, crossover trial in patients tolerating oral therapy","volume":"114","author":"Pritchett","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1067\/mhj.2001.115439_bib5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0002-8703(97)70186-8","article-title":"Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias","volume":"133","author":"Wanless","year":"1997","journal-title":"Am Heart J"},{"issue":"8A Suppl","key":"10.1067\/mhj.2001.115439_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-9149(96)00564-4","article-title":"Proarrhythmia during drug treatment of supraventricular tachycardia: paradoxical risk of sinus rhythm for sudden death","volume":"78","author":"Prystowsky","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2001.115439_bib7","first-page":"2550","article-title":"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation","volume":"92","author":"UK Propafenone PSVT Study Group","year":"1995","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.115439_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/01.CIR.83.1.119","article-title":"Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia","volume":"83","author":"Henthorn","year":"1991","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.115439_bib9","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.CIR.82.4.1106","article-title":"Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a meta-analysis of randomized control trials","volume":"82","author":"Coplen","year":"1990","journal-title":"Circulation"},{"issue":"H Suppl","key":"10.1067\/mhj.2001.115439_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/eurheartj\/14.suppl_H.14","article-title":"Arrhythmia control by prolonging repolarization: the concept and its potential therapeutic impact","volume":"14","author":"Singh","year":"1993","journal-title":"Eur Heart J"},{"key":"10.1067\/mhj.2001.115439_bib11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2125.1991.tb05572.x","article-title":"Pharmacokinetic and pharmacodynamic effects of UK-68,798, a new potential class III antiarrhythmic drug","volume":"31","author":"Sedgwick","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.1067\/mhj.2001.115439_bib12","first-page":"318","article-title":"UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells","volume":"256","author":"Gwilt","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1067\/mhj.2001.115439_bib13","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/j.1476-5381.1991.tb09828.x","article-title":"Rate and concentration-dependent effects of UK-68,798, a potent new class III antiarrhythmic, on canine Purkinje fibre action potential duration and Vmax","volume":"103","author":"Knilans","year":"1991","journal-title":"Br J Pharmacol"},{"issue":"Suppl","key":"10.1067\/mhj.2001.115439_bib14","first-page":"661","article-title":"Conversion of AF and maintenance of sinus rhythm by dofetilide [abstract P3682]","volume":"19","author":"Greenbaum","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1067\/mhj.2001.115439_bib15","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1161\/01.CIR.102.19.2385","article-title":"Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study","volume":"102","author":"Singh","year":"2000","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.115439_bib16","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2001.115439_bib17","first-page":"867","article-title":"Electrophysiologic and hemodynamic effects of dofetilide in patients with depressed left ventricular function: a randomized, double-blind, placebo-controlled study","volume":"21","author":"Nademanee","year":"1998","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1067\/mhj.2001.115439_bib18","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM199909163411201","article-title":"Dofetilide in patients with congestive heart failure and left ventricular dysfunction","volume":"341","author":"Torp-Pedersen","year":"1999","journal-title":"N Engl J Med"},{"issue":"17 Suppl","key":"10.1067\/mhj.2001.115439_bib19","first-page":"I93","article-title":"A clinical trial of dofetilide in patients with acute myocardial infarction and left ventricular dysfunction: the DIAMOND MI study [abstract 471]","volume":"98","author":"Kober","year":"1998","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870301998370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870301998370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T07:20:31Z","timestamp":1557386431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870301998370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["S0002870301998370"],"URL":"https:\/\/doi.org\/10.1067\/mhj.2001.115439","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}